Biblio Discovery — Demo Discovery Service

3 hasil untuk "Alexander C. Angleitner"

Menampilkan 1–3 · 0,27 detik · RSS

  1. Artikel Jurnal

    Δ-β2M as a dynamic biomarker for predicting ICU admission after CAR T-cell therapy

    Alexander C. Angleitner; Markus Maulhardt; Kristian Thomson dkk.

    Annals of Hematology, Vol. 105 No. 6 · 2026 · Inggris · DOAJ Scopus

    Abstract CAR T-cell therapy is associated with life-threatening toxicities requiring intensive care unit (ICU) admission. Reliable biomarkers for early risk stratification are lacking. We evaluated Δ-β2-microglobulin (Δ-β2M) as a dynamic biomarker for predicting ICU admission after CAR T-cell…

  2. Artikel Jurnal

    Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS

    Alexander C. Angleitner; Markus Maulhardt; Justin Hasenkamp dkk.

    Frontiers in Hematology, Vol. 5 · 2026 · Inggris · DOAJ Scopus

    BackgroundRelapse is the main cause of treatment failure after allogeneic hematopoietic cell transplantation (allo-HCT). Therapeutic donor lymphocyte infusion (DLI) and second allo-HCT are common post-relapse options, but comparative evidence from the time of relapse is limited.MethodsWe…

  3. Artikel Jurnal

    Timing of donor lymphocyte infusion after relapse following allogeneic hematopoietic cell transplantation: a retrospective single-center analysis

    Alexander C. Angleitner; Markus Maulhardt; Hannes Treiber dkk.

    Annals of Hematology, Vol. 105 No. 6 · 2026 · Inggris · DOAJ Scopus

    Abstract Donor lymphocyte infusions (DLI) are an important strategy for managing relapse after allogeneic hematopoietic stem cell transplantation (allo-HCT), yet data on the impact of surveillance frequency and DLI timing remain limited. We retrospectively analyzed 83 adults with acute leukemia or…